MRVI
HEALTHCAREMaravai LifeSciences Holdings Inc - Class A
$3.94+0.09 (+2.34%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving MRVI Today?
No stock-specific AI insight has been generated for MRVI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.95$4.11
$3.94
Fundamentals
Market Cap$1.5B
P/E Ratio—
EPS$-0.90
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume3.6M
Avg Volume (10D)—
Shares Outstanding147.5M
MRVI News
20 articles- Maravai LifeSciences Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·May 7, 2026
- Maravai LifeSciences Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to BuyYahoo Finance·May 6, 2026
- Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026Yahoo Finance·Apr 20, 2026
- Maravai LifeSciences (MRVI) Carrying Moderately Bullish Sentiment Despite Options-Linked VolatilityYahoo Finance·Apr 14, 2026
- How Maravai LifeSciences (MRVI) Q4 Results Are Shaping A Cautious Valuation NarrativeYahoo Finance·Apr 13, 2026
- How The Maravai LifeSciences (MRVI) Story Is Shifting As Analysts Rework Fair Value TargetsYahoo Finance·Mar 30, 2026
- Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 26, 2026
- Maravai LifeSciences Q4 Earnings Call HighlightsMarketbeat·Feb 26, 2026
- Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Feb 26, 2026
- Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 25, 2026
- February 2026's Undervalued Small Caps With Insider Actions To ConsiderYahoo Finance·Feb 19, 2026
- Is There An Opportunity With Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 34% Undervaluation?Yahoo Finance·Feb 16, 2026
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026Yahoo Finance·Feb 9, 2026
- What to Know About a New $9 Million Bet on an Energy Distributor StockMotley Fool·Feb 6, 2026
- This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million ExitMotley Fool·Feb 6, 2026
- 3 Undervalued Small Caps With Insider Buying Across RegionsYahoo Finance·Jan 6, 2026
- Why Analysts See Maravai’s Story Shifting After Target Cut And Washed Out Share Price RangeYahoo Finance·Dec 16, 2025
- Why Analysts See Opportunity and Risk as Maravai’s Story Evolves After Management ShakeupYahoo Finance·Dec 2, 2025
All 20 articles loaded
Price Data
Open$3.70
Previous Close$3.85
Day High$3.82
Day Low$3.63
52 Week High$4.11
52 Week Low$1.95
52-Week Range
$1.95$4.11
$3.94
Fundamentals
Market Cap$1.5B
P/E Ratio—
EPS$-0.90
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume3.6M
Avg Volume (10D)—
Shares Outstanding147.5M
About Maravai LifeSciences Holdings Inc - Class A
Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines, and to support human disease research in the United States and internationally. The company is headquartered in San Diego, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—